A Phase II Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Adrenocortical Carcinoma

BACKGROUND: Recurrent adrenocortical carcinoma (ACC) is an aggressive disease with few options offering durable survival benefit. Despite metastasectomy, recurrence is common. Cytoreduction and intraperitoneal chemotherapy have offered improved survival in other advanced cancers. We sought to evalua...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Surg Res
Auteurs principaux: Hughes, Marybeth S., Lo, Winifred M., Beresnev, Tatiana, Merino, Maria, Shutack, Yvonne, Ripley, R. Taylor, Hernandez, Jonathan M., Davis, Jeremy L.
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8054912/
https://ncbi.nlm.nih.gov/pubmed/30463745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jss.2018.06.012
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires